-10.50 (-0.84%) Dr. Reddys Laboratories has informed that it has enclosed a Press Release on 17th September 2020 titled ‘Dr. Reddy’s announces the launch of Over-the-Counter Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% and 0.1%, the store-brand equivalent of Pataday®, the Eye Allergy Drop in the U.S. Market’.
The above information is a part of company’s filings submitted to BSE.